Hoehn A - Search Results

1

Development of de novo cancer in p53 knock-out mice is dependent on the type of long-term immunosuppression used.

Koehl GE, Gaumann A, Zuelke C, Hoehn A, Hofstaedter F, Schlitt HJ, Geissler EK. Koehl GE, et al. Among authors: hoehn a. Transplantation. 2006 Sep 27;82(6):741-8. doi: 10.1097/01.tp.0000233852.75162.74. Transplantation. 2006. PMID: 17006319

2

Rapamycin-induced endothelial cell death and tumor vessel thrombosis potentiate cytotoxic therapy against pancreatic cancer.

Bruns CJ, Koehl GE, Guba M, Yezhelyev M, Steinbauer M, Seeliger H, Schwend A, Hoehn A, Jauch KW, Geissler EK. Bruns CJ, et al. Among authors: hoehn a. Clin Cancer Res. 2004 Mar 15;10(6):2109-19. doi: 10.1158/1078-0432.ccr-03-0502. Clin Cancer Res. 2004. PMID: 15041732

3

How could 20-minute neighbourhoods impact health and health inequalities? A policy scoping review.

Pollack R, Olsen JR, Heppenstall A, Hoehn A, Boyd J, Hardy VP, Littlejohn J, Stevenson A, Mitchell R, Meier P, Stokes J. Pollack R, et al. Among authors: hoehn a. BMC Public Health. 2024 Dec 18;24(1):3426. doi: 10.1186/s12889-024-20928-5. BMC Public Health. 2024. PMID: 39696117 Free PMC article. Review.

4

Differentiating patients admitted primarily due to coronavirus disease 2019 (COVID-19) from those admitted with incidentally detected severe acute respiratory syndrome corona-virus type 2 (SARS-CoV-2) at hospital admission: A cohort analysis of German hospital records.

Strobl R, Misailovski M, Blaschke S, Berens M, Beste A, Krone M, Eisenmann M, Ebert S, Hoehn A, Mees J, Kaase M, Chackalackal DJ, Koller D, Chrampanis J, Kosub JM, Srivastava N, Albashiti F, Groß U, Fischer A, Grill E, Scheithauer S. Strobl R, et al. Among authors: hoehn a. Infect Control Hosp Epidemiol. 2024 Jun;45(6):746-753. doi: 10.1017/ice.2024.3. Epub 2024 Feb 14. Infect Control Hosp Epidemiol. 2024. PMID: 38351873 Free PMC article.

5

Theoretical Examination of the Hydroxide Transport in Cobaltocenium-Containing Polyelectrolytes.

Wickramasinghe S, Hoehn A, Wetthasinghe ST, Lin H, Wang Q, Jakowski J, Rassolov V, Tang C, Garashchuk S. Wickramasinghe S, et al. Among authors: hoehn a. J Phys Chem B. 2023 Nov 30;127(47):10129-10141. doi: 10.1021/acs.jpcb.3c04118. Epub 2023 Nov 16. J Phys Chem B. 2023. PMID: 37972315

6

CT Texture Analysis and Node-RADS CT Score of Lymph Nodes in Patients With Perihilar Cholangiocarcinoma.

Leonhardi J, Sabanov A, Schnarkowski B, Hoehn AK, Sucher R, Seehofer D, Denecke T, Meyer HJ. Leonhardi J, et al. Among authors: hoehn ak. Anticancer Res. 2023 Nov;43(11):5089-5097. doi: 10.21873/anticanres.16709. Anticancer Res. 2023. PMID: 37909955

7

Quadrivalent neuraminidase RNA particle vaccine protects pigs against homologous and heterologous strains of swine influenza virus infection.

Kitikoon P, Knetter SM, Mogler MA, Morgan CL, Hoehn A, Puttamreddy S, Strait EL, Segers RPAM. Kitikoon P, et al. Among authors: hoehn a. Vaccine. 2023 Nov 13;41(47):6941-6951. doi: 10.1016/j.vaccine.2023.10.005. Epub 2023 Oct 24. Vaccine. 2023. PMID: 37884412 Free article.

8

Cost-Utility Comparison of Bevacizumab and Aflibercept in the Treatment of Central or Hemiretinal Vein Occlusion in the SCORE2 Trial.

Kymes SM, Oden NL, VanVeldhuisen PC, Scott IU, Ip MS, Blodi BA, King J; SCORE2 Investigator Group. Kymes SM, et al. JAMA Ophthalmol. 2023 Jun 1;141(6):554-561. doi: 10.1001/jamaophthalmol.2023.1463. JAMA Ophthalmol. 2023. PMID: 37166820 Free PMC article.

9

Developing the Florida Academic Cancer Center Alliance Health Disparities Common Measure: The Florida Health and Ancestry Survey.

Dyal BW, Uscanga ZL, Bailey Z, Schmit S, Hoehn A, Garcia J, Gwede CK, Brownstein N, Powell-Roach K, Johnson-Mallard V, Krieger JL, Kobetz E, Vadaparampil S, Odedina FT, Wilkie DJ. Dyal BW, et al. Among authors: hoehn a. Cancer Control. 2022 Jan-Dec;29:10732748221110897. doi: 10.1177/10732748221110897. Cancer Control. 2022. PMID: 35758601 Free PMC article.

10

Baseline Characteristics and Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared With Participants With Central Retinal Vein Occlusion: Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Report 18.

Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA; SCORE2 Study Investigator Group. Scott IU, et al. JAMA Ophthalmol. 2022 May 1;140(5):458-464. doi: 10.1001/jamaophthalmol.2022.0352. JAMA Ophthalmol. 2022. PMID: 35323843 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters